BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colwell N, Larion M, Giles AJ, Seldomridge AN, Sizdahkhani S, Gilbert MR, Park DM. Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells. Neuro Oncol 2017;19:887-96. [PMID: 28339582 DOI: 10.1093/neuonc/now258] [Cited by in Crossref: 125] [Cited by in F6Publishing: 130] [Article Influence: 31.3] [Reference Citation Analysis]
Number Citing Articles
1 Petterson SA, Sørensen MD, Burton M, Thomassen M, Kruse TA, Michaelsen SR, Kristensen BW. Differential expression of checkpoint markers in the normoxic and hypoxic microenvironment of glioblastomas. Brain Pathol 2022;:e13111. [PMID: 36093941 DOI: 10.1111/bpa.13111] [Reference Citation Analysis]
2 Culley J, Nagle PW, Dawson JC, Carragher NO. Patient derived glioma stem cell spheroid reporter assays for live cell high content analysis. SLAS Discovery 2022. [DOI: 10.1016/j.slasd.2022.09.002] [Reference Citation Analysis]
3 Shi W, Ding W, Zhao Z, Wang R, Wang F, Tang Y, Zhu J, Su C, Zhao X, Liu L. Peroxidase is a novel potential marker in glioblastoma through bioinformatics method and experimental validation. Front Genet 2022;13:990344. [DOI: 10.3389/fgene.2022.990344] [Reference Citation Analysis]
4 Fiz F, Bottoni G, Ugolini M, Righi S, Cirone A, Garganese MC, Verrico A, Rossi A, Milanaccio C, Ramaglia A, Mastronuzzi A, Abate ME, Cacchione A, Gandolfo C, Colafati GS, Garrè ML, Morana G, Piccardo A. Diagnostic and Dosimetry Features of [64Cu]CuCl2 in High-Grade Paediatric Infiltrative Gliomas. Mol Imaging Biol 2022. [PMID: 36042116 DOI: 10.1007/s11307-022-01769-3] [Reference Citation Analysis]
5 Qiu J, Wu K, Zhu M, Chen CY, Luo Y, Liu Y, Wen J. Using quantitative MRI to study the association of isocitrate dehydrogenase (IDH) status with oxygen metabolism and cellular structure changes in glioma. Eur J Radiol 2022;155:110502. [PMID: 36049408 DOI: 10.1016/j.ejrad.2022.110502] [Reference Citation Analysis]
6 Rosa P, Scibetta S, Pepe G, Mangino G, Capocci L, Moons SJ, Boltje TJ, Fazi F, Petrozza V, Di Pardo A, Maglione V, Calogero A. Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells. IJMS 2022;23:9563. [DOI: 10.3390/ijms23179563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Zhang G, Tao X, Ji B, Gong J, Ciriolo MR. Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-20. [DOI: 10.1155/2022/1614336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bova V, Filippone A, Casili G, Lanza M, Campolo M, Capra AP, Repici A, Crupi L, Motta G, Colarossi C, Chisari G, Cuzzocrea S, Esposito E, Paterniti I. Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness. Cancers (Basel) 2022;14:4032. [PMID: 36011024 DOI: 10.3390/cancers14164032] [Reference Citation Analysis]
9 Rocha JD, Uribe D, Delgado J, Niechi I, Alarcón S, Erices JI, Melo R, Fernández-Gajardo R, Salazar-Onfray F, San Martín R, Quezada Monrás C. A2B Adenosine Receptor Enhances Chemoresistance of Glioblastoma Stem-Like Cells under Hypoxia: New Insights into MRP3 Transporter Function. Int J Mol Sci 2022;23:9022. [PMID: 36012307 DOI: 10.3390/ijms23169022] [Reference Citation Analysis]
10 Yan J, Hanif S, Zhang D, Ismail M, Wang X, Li Q, Shi B, Muhammad P, Wu H. Arsenic Prodrug-Mediated Tumor Microenvironment Modulation Platform for Synergetic Glioblastoma Therapy. ACS Appl Mater Interfaces 2022. [PMID: 35921662 DOI: 10.1021/acsami.2c12076] [Reference Citation Analysis]
11 Tiwari M, Kumar Sharma L, Kumar Saxena A. Potential Role of Cancer Stem Cells in Glioblastoma: A Therapeutic Aspect. Glioblastoma - Current Evidences [Working Title] 2022. [DOI: 10.5772/intechopen.106332] [Reference Citation Analysis]
12 Muhammad P, Hanif S, Li J, Guller A, Rehman FU, Ismail M, Zhang D, Yan X, Fan K, Shi B. Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway. Nano Today 2022;45:101530. [DOI: 10.1016/j.nantod.2022.101530] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
13 Zhu L, Liu J, Qiu M, Chen J, Liang Q, Peng G, Zou Z. Bacteria-mediated metformin-loaded peptide hydrogel reprograms the tumor immune microenvironment in glioblastoma. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121711] [Reference Citation Analysis]
14 Liu D, Wan Y, Qu N, Fu Q, Liang C, Zeng L, Yang Y. LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma. Front Public Health 2022;10:898270. [PMID: 35874989 DOI: 10.3389/fpubh.2022.898270] [Reference Citation Analysis]
15 Wang K, Wang J, Zhang J, Zhang A, Liu Y, Zhou J, Wang X, Zhang J. Ferroptosis in Glioma Immune Microenvironment: Opportunity and Challenge. Front Oncol 2022;12:917634. [PMID: 35832539 DOI: 10.3389/fonc.2022.917634] [Reference Citation Analysis]
16 Hide T, Shibahara I, Inukai M, Shigeeda R, Kumabe T. Ribosomes and Ribosomal Proteins Promote Plasticity and Stemness Induction in Glioma Cells via Reprogramming. Cells 2022;11:2142. [DOI: 10.3390/cells11142142] [Reference Citation Analysis]
17 Tatari N, Zhang X, Chafe SC, Mckenna D, Lawson KA, Subapanditha M, Shaikh MV, Seyfrid M, Savage N, Venugopal C, Moffat J, Singh SK. Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors. Front Immunol 2022;13:905768. [DOI: 10.3389/fimmu.2022.905768] [Reference Citation Analysis]
18 Wang M, Zhou Z, Wang X, Zhang C, Jiang X. Natural killer cell awakening: unleash cancer-immunity cycle against glioblastoma. Cell Death Dis 2022;13:588. [DOI: 10.1038/s41419-022-05041-y] [Reference Citation Analysis]
19 Ma K, Chen S, Chen X, Yang C, Yang J. S100A10 Is a New Prognostic Biomarker Related to the Malignant Molecular Features and Immunosuppression Process of Adult Gliomas. World Neurosurg 2022:S1878-8750(22)00909-3. [PMID: 35779750 DOI: 10.1016/j.wneu.2022.06.124] [Reference Citation Analysis]
20 Liu Y, Shi Y, Wu M, Liu J, Wu H, Xu C, Chen L. Hypoxia-induced polypoid giant cancer cells in glioma promote the transformation of tumor-associated macrophages to a tumor-supportive phenotype. CNS Neurosci Ther 2022. [PMID: 35762580 DOI: 10.1111/cns.13892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Shrivastava R, Gandhi P, Gothalwal R. The road-map for establishment of a prognostic molecular marker panel in glioma using liquid biopsy: current status and future directions. Clin Transl Oncol 2022. [PMID: 35653004 DOI: 10.1007/s12094-022-02833-8] [Reference Citation Analysis]
22 Kang H, Lee H, Kim D, Kim B, Kang J, Kim HY, Youn H, Youn B. Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies. Biomedicines 2022;10:1308. [DOI: 10.3390/biomedicines10061308] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
23 Zhang W, Gong P, Tian Q, Han S, Wang J, He P, Guo Y, Wang G, Chen Q, Huang J, Li M, Yang D. The eIF4A Inhibitor Silvestrol Blocks the Growth of Human Glioblastoma Cells by Inhibiting AKT/mTOR and ERK1/2 Signaling Pathway. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/4396316] [Reference Citation Analysis]
24 Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers 2022;14:2520. [DOI: 10.3390/cancers14102520] [Reference Citation Analysis]
25 Smith PJ, McKeown SR, Patterson LH. Targeting DNA topoisomerase IIα (TOP2A) in the hypoxic tumour microenvironment using unidirectional hypoxia-activated prodrugs (uHAPs). IUBMB Life 2022. [PMID: 35499745 DOI: 10.1002/iub.2619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Denner TC, Hoenke S, Kraft O, Deigner H, Al-harrasi A, Csuk R. Hydroxyethylamide substituted triterpenoic acids hold good cytotoxicity for human tumor cells. Results in Chemistry 2022. [DOI: 10.1016/j.rechem.2022.100371] [Reference Citation Analysis]
27 Torrisi F, Alberghina C, D’aprile S, Pavone AM, Longhitano L, Giallongo S, Tibullo D, Di Rosa M, Zappalà A, Cammarata FP, Russo G, Ippolito M, Cuttone G, Li Volti G, Vicario N, Parenti R. The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and Progression. Biomedicines 2022;10:806. [DOI: 10.3390/biomedicines10040806] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
28 Amini P, Amrovani M, Nassaj ZS, Ajorlou P, Pezeshgi A, Ghahrodizadehabyaneh B. Hypertension: Potential Player in Cardiovascular Disease Incidence in Preeclampsia. Cardiovasc Toxicol 2022;22:391-403. [PMID: 35347585 DOI: 10.1007/s12012-022-09734-w] [Reference Citation Analysis]
29 Di Nunno V, Franceschi E, Tosoni A, Gatto L, Bartolini S, Brandes AA. Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance. Front Oncol 2022;12:852950. [PMID: 35311140 DOI: 10.3389/fonc.2022.852950] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Pancholi S, Tripathi A, Bhan A, Acharya MM, Pillai P. Emerging Concepts on the Role of Extracellular Vesicles and Its Cargo Contents in Glioblastoma-Microglial Crosstalk. Mol Neurobiol 2022. [PMID: 35212938 DOI: 10.1007/s12035-022-02752-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Wang K, Lu Y, Liu Z, Diao M, Yang L, Gm S. Establishment and External Validation of a Hypoxia-Derived Gene Signature for Robustly Predicting Prognosis and Therapeutic Responses in Glioblastoma Multiforme. BioMed Research International 2022;2022:1-50. [DOI: 10.1155/2022/7858477] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Waqar M, Trifiletti DM, McBain C, O'Connor J, Coope DJ, Akkari L, Quinones-Hinojosa A, Borst GR. Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature. Curr Oncol Rep 2022. [PMID: 35119629 DOI: 10.1007/s11912-021-01157-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Stumpo V, Sebök M, van Niftrik CHB, Seystahl K, Hainc N, Kulcsar Z, Weller M, Regli L, Fierstra J. Feasibility of glioblastoma tissue response mapping with physiologic BOLD imaging using precise oxygen and carbon dioxide challenge. MAGMA 2022;35:29-44. [PMID: 34874499 DOI: 10.1007/s10334-021-00980-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Guha A, Waris S, Nabors LB, Filippova N, Gorospe M, Kwan T, King PH. The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack. Adv Drug Deliv Rev 2022;181:114082. [PMID: 34923029 DOI: 10.1016/j.addr.2021.114082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
35 Horak VJ, Mishory A, Baisiwala S, Ahmed AU. Understanding the Role of Plasticity in Glioblastoma. Comprehensive Pharmacology 2022. [DOI: 10.1016/b978-0-12-820472-6.00062-1] [Reference Citation Analysis]
36 Domènech M, Hernández A, Plaja A, Martínez-Balibrea E, Balañà C. Hypoxia: The Cornerstone of Glioblastoma. Int J Mol Sci 2021;22:12608. [PMID: 34830491 DOI: 10.3390/ijms222212608] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 15.0] [Reference Citation Analysis]
37 Daubon T, Magaut R, Bikfalvi A. Tumor Cell Invasion and the Tumor Microenvironment: Special Focus on Brain Tumors. Adv Exp Med Biol 2021;1329:109-21. [PMID: 34664236 DOI: 10.1007/978-3-030-73119-9_6] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Xu S, Tang L, Liu Z, Luo C, Cheng Q. Hypoxia-Related lncRNA Correlates With Prognosis and Immune Microenvironment in Lower-Grade Glioma. Front Immunol 2021;12:731048. [PMID: 34659218 DOI: 10.3389/fimmu.2021.731048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
39 Li Z, Du G, Zhao R, Yang W, Li C, Huang J, Wen Z, Li H, Zhang B. Identification and validation of a hypoxia-related prognostic signature in clear cell renal cell carcinoma patients. Medicine (Baltimore) 2021;100:e27374. [PMID: 34596153 DOI: 10.1097/MD.0000000000027374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
40 Tatla AS, Justin AW, Watts C, Markaki AE. A vascularized tumoroid model for human glioblastoma angiogenesis. Sci Rep 2021;11:19550. [PMID: 34599235 DOI: 10.1038/s41598-021-98911-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
41 Troike KM, Acanda de la Rocha AM, Alban TJ, Grabowski MM, Otvos B, Cioffi G, Waite KA, Barnholtz Sloan JS, Lathia JD, Guilarte TR, Azzam DJ. The Translocator Protein (TSPO) Genetic Polymorphism A147T Is Associated with Worse Survival in Male Glioblastoma Patients. Cancers (Basel) 2021;13:4525. [PMID: 34572751 DOI: 10.3390/cancers13184525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Paul R, Dorsey JF, Fan Y. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications. Pharmacol Ther 2021;:107985. [PMID: 34480963 DOI: 10.1016/j.pharmthera.2021.107985] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
43 Lefranc F. Transient Receptor Potential (TRP) Ion Channels Involved in Malignant Glioma Cell Death and Therapeutic Perspectives. Front Cell Dev Biol 2021;9:618961. [PMID: 34458247 DOI: 10.3389/fcell.2021.618961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 D'Amico AG, Maugeri G, Vanella L, Pittalà V, Reglodi D, D'Agata V. Multimodal Role of PACAP in Glioblastoma. Brain Sci 2021;11:994. [PMID: 34439613 DOI: 10.3390/brainsci11080994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
45 Chen H, Pan Y, Jin X, Chen G. Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma. Front Oncol 2021;11:713346. [PMID: 34386428 DOI: 10.3389/fonc.2021.713346] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
46 Tang X, Zuo C, Fang P, Liu G, Qiu Y, Huang Y, Tang R. Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy. Front Oncol 2021;11:701291. [PMID: 34307170 DOI: 10.3389/fonc.2021.701291] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
47 Murphy DA, Cheng H, Yang T, Yan X, Adjei IM. Reversing Hypoxia with PLGA-Encapsulated Manganese Dioxide Nanoparticles Improves Natural Killer Cell Response to Tumor Spheroids. Mol Pharm 2021;18:2935-46. [PMID: 34191525 DOI: 10.1021/acs.molpharmaceut.1c00085] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 10.0] [Reference Citation Analysis]
48 Chen Z, Chen Y, Li Y, Lian W, Zheng K, Zhang Y, Zhang Y, Lin C, Liu C, Sun F, Sun X, Wang J, Zhao L, Ke Y. Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma. Cell Death Dis 2021;12:615. [PMID: 34131109 DOI: 10.1038/s41419-021-03882-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
49 Qiao S, Cheng Y, Liu M, Ji Q, Zhang B, Mei Q, Liu D, Zhou S. Chemoattractants driven and microglia based biomimetic nanoparticle treating TMZ-resistant glioblastoma multiforme. J Control Release 2021;336:54-70. [PMID: 34129862 DOI: 10.1016/j.jconrel.2021.06.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
50 Qiu R, Zhong Y, Li Q, Li Y, Fan H. Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors. Front Cell Dev Biol 2021;9:693215. [PMID: 34211978 DOI: 10.3389/fcell.2021.693215] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
51 Alhalhooly L, Mamnoon B, Kim J, Mallik S, Choi Y. Dynamic cellular biomechanics in responses to chemotherapeutic drug in hypoxia probed by atomic force spectroscopy. Oncotarget 2021;12:1165-77. [PMID: 34136085 DOI: 10.18632/oncotarget.27974] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
52 Cao C, He K, Li S, Ge Q, Liu L, Zhang Z, Zhang H, Wang X, Sun X, Ding L. ITPRIP promotes glioma progression by linking MYL9 to DAPK1 inhibition. Cell Signal 2021;85:110062. [PMID: 34111521 DOI: 10.1016/j.cellsig.2021.110062] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Noch EK, Sait SF, Farooq S, Trippett TM, Miller AM. A case series of extraneural metastatic glioblastoma at Memorial Sloan Kettering Cancer Center. Neurooncol Pract 2021;8:325-36. [PMID: 34055380 DOI: 10.1093/nop/npaa083] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
54 Jaroch K, Modrakowska P, Bojko B. Glioblastoma Metabolomics-In Vitro Studies. Metabolites 2021;11:315. [PMID: 34068300 DOI: 10.3390/metabo11050315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Wang P, Gong S, Pan J, Wang J, Zou D, Xiong S, Zhao L, Yan Q, Deng Y, Wu N, Liao B. Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2. Cell Death Discov 2021;7:103. [PMID: 33986256 DOI: 10.1038/s41420-021-00486-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
56 Kawai T, Brender JR, Lee JA, Kramp T, Kishimoto S, Krishna MC, Tofilon P, Camphausen KA. Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized 13 C-MRI. NMR Biomed 2021;34:e4514. [PMID: 33939204 DOI: 10.1002/nbm.4514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
57 Tran K, Brice R, Yao L. Bioscaffold-based study of glioblastoma cell behavior and drug delivery for tumor therapy. Neurochem Int 2021;147:105049. [PMID: 33945833 DOI: 10.1016/j.neuint.2021.105049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Leblanc V, Trinh D, Aslanpour S, Hughes M, Livingstone D, Blough M, Cairncross J, Chan J, Kelly J, Marra M. Single-cell landscapes of primary glioblastomas and matched organoids and cell lines reveal variable retention of inter- and intra-tumor heterogeneity.. [DOI: 10.1101/2021.04.24.441206] [Reference Citation Analysis]
59 Di Ianni N, Musio S, Pellegatta S. Altered Metabolism in Glioblastoma: Myeloid-Derived Suppressor Cell (MDSC) Fitness and Tumor-Infiltrating Lymphocyte (TIL) Dysfunction. Int J Mol Sci 2021;22:4460. [PMID: 33923299 DOI: 10.3390/ijms22094460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
60 Xu J, Zhang J, Zhang Z, Gao Z, Qi Y, Qiu W, Pan Z, Guo Q, Li B, Zhao S, Guo X, Qian M, Chen Z, Wang S, Gao X, Zhang S, Wang H, Guo X, Zhang P, Zhao R, Xue H, Li G. Hypoxic glioma-derived exosomes promote M2-like macrophage polarization by enhancing autophagy induction. Cell Death Dis 2021;12:373. [PMID: 33828078 DOI: 10.1038/s41419-021-03664-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 29.0] [Reference Citation Analysis]
61 Zhu H, Yu X, Zhang S, Shu K. Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front Cell Dev Biol 2021;9:657472. [PMID: 33869223 DOI: 10.3389/fcell.2021.657472] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
62 Stanković T, Ranđelović T, Dragoj M, Stojković Burić S, Fernández L, Ochoa I, Pérez-García VM, Pešić M. In vitro biomimetic models for glioblastoma-a promising tool for drug response studies. Drug Resist Updat 2021;55:100753. [PMID: 33667959 DOI: 10.1016/j.drup.2021.100753] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
63 Cheng HS, Marvalim C, Zhu P, Law CLD, Low ZYJ, Chong YK, Ang BT, Tang C, Tan NS. Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation. Theranostics 2021;11:5127-42. [PMID: 33859738 DOI: 10.7150/thno.54741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Arienti C, Pignatta S, Zanoni M, Zamagni A, Cortesi M, Sarnelli A, Romeo A, Arpa D, Longobardi P, Bartolini D, Tosatto L, Naldini A, Tesei A. High-pressure oxygen rewires glucose metabolism of patient-derived glioblastoma cells and fuels inflammasome response. Cancer Lett 2021;506:152-66. [PMID: 33652086 DOI: 10.1016/j.canlet.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
65 Gaete D, Rodriguez D, Watts D, Sormendi S, Chavakis T, Wielockx B. HIF-Prolyl Hydroxylase Domain Proteins (PHDs) in Cancer-Potential Targets for Anti-Tumor Therapy? Cancers (Basel) 2021;13:988. [PMID: 33673417 DOI: 10.3390/cancers13050988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
66 Alon S, Goodwin DR, Sinha A, Wassie AT, Chen F, Daugharthy ER, Bando Y, Kajita A, Xue AG, Marrett K, Prior R, Cui Y, Payne AC, Yao CC, Suk HJ, Wang R, Yu CJ, Tillberg P, Reginato P, Pak N, Liu S, Punthambaker S, Iyer EPR, Kohman RE, Miller JA, Lein ES, Lako A, Cullen N, Rodig S, Helvie K, Abravanel DL, Wagle N, Johnson BE, Klughammer J, Slyper M, Waldman J, Jané-Valbuena J, Rozenblatt-Rosen O, Regev A, Church GM, Marblestone AH, Boyden ES; IMAXT Consortium. Expansion sequencing: Spatially precise in situ transcriptomics in intact biological systems. Science 2021;371:eaax2656. [PMID: 33509999 DOI: 10.1126/science.aax2656] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 98.0] [Reference Citation Analysis]
67 Lauko A, Lo A, Ahluwalia MS, Lathia JD. Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors. Semin Cancer Biol 2021:S1044-579X(21)00049-3. [PMID: 33640445 DOI: 10.1016/j.semcancer.2021.02.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 16.0] [Reference Citation Analysis]
68 Lo Dico A, Martelli C, Diceglie C, Ottobrini L. The Multifaceted Role of CMA in Glioma: Enemy or Ally? Int J Mol Sci 2021;22:2217. [PMID: 33672324 DOI: 10.3390/ijms22042217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
69 Chelliah SS, Paul EAL, Kamarudin MNA, Parhar I. Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas. Molecules 2021;26:1169. [PMID: 33671796 DOI: 10.3390/molecules26041169] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
70 Huff S, Tiwari SK, Gonzalez GM, Wang Y, Rana TM. m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells. ACS Chem Biol 2021;16:324-33. [PMID: 33412003 DOI: 10.1021/acschembio.0c00841] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
71 Tudor T, Binder ZA, O'Rourke DM. CAR T Cells. Neurosurg Clin N Am 2021;32:249-63. [PMID: 33781506 DOI: 10.1016/j.nec.2020.12.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
72 Tatla AS, Justin AW, Watts C, Markaki AE. A Vascularized Tumoroid Model for Human Glioblastoma Angiogenesis.. [DOI: 10.1101/2021.02.05.429930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, Nedaeinia R, Haghjooy Javanmard S, Taherian M, Ahmadlou M, Salehi R, Sadeghi B, Manian M. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int 2021;21:62. [PMID: 33472628 DOI: 10.1186/s12935-020-01719-5] [Cited by in Crossref: 80] [Cited by in F6Publishing: 95] [Article Influence: 80.0] [Reference Citation Analysis]
74 Siebzehnrubl FA. Proteoglycans in Glioma Stem Cells. Proteoglycans in Stem Cells 2021. [DOI: 10.1007/978-3-030-73453-4_11] [Reference Citation Analysis]
75 Ghosalkar J, Sonawane V, Khan M, Joshi K, Shastry P. Prostate Apoptosis Response-4: a Therapeutic Target for Malignant Gliomas. Tumor Suppressor Par-4 2021. [DOI: 10.1007/978-3-030-80558-6_6] [Reference Citation Analysis]
76 Nikolopoulos M, Das S. Signaling in the tumor microenvironment of therapy-resistant glioblastoma. Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative Reversal Strategies 2021. [DOI: 10.1016/b978-0-12-821567-8.00004-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Boyd NH, Tran AN, Bernstock JD, Etminan T, Jones AB, Gillespie GY, Friedman GK, Hjelmeland AB. Glioma stem cells and their roles within the hypoxic tumor microenvironment. Theranostics 2021;11:665-83. [PMID: 33391498 DOI: 10.7150/thno.41692] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 30.0] [Reference Citation Analysis]
78 Ruiz-Rodado V, Brender JR, Cherukuri MK, Gilbert MR, Larion M. Magnetic resonance spectroscopy for the study of cns malignancies. Prog Nucl Magn Reson Spectrosc 2021;122:23-41. [PMID: 33632416 DOI: 10.1016/j.pnmrs.2020.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
79 Attwood KM, Robichaud A, Westhaver LP, Castle EL, Brandman DM, Balgi AD, Roberge M, Colp P, Croul S, Kim I, McCormick C, Corcoran JA, Weeks A. Raloxifene prevents stress granule dissolution, impairs translational control and promotes cell death during hypoxia in glioblastoma cells. Cell Death Dis 2020;11:989. [PMID: 33203845 DOI: 10.1038/s41419-020-03159-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
80 Coelho BP, Fernandes CFL, Boccacino JM, Souza MCDS, Melo-Escobar MI, Alves RN, Prado MB, Iglesia RP, Cangiano G, Mazzaro GR, Lopes MH. Multifaceted WNT Signaling at the Crossroads Between Epithelial-Mesenchymal Transition and Autophagy in Glioblastoma. Front Oncol. 2020;10:597743. [PMID: 33312955 DOI: 10.3389/fonc.2020.597743] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
81 Guo L, Li H, Li W, Tang J. Construction and investigation of a combined hypoxia and stemness index lncRNA-associated ceRNA regulatory network in lung adenocarcinoma. BMC Med Genomics 2020;13:166. [PMID: 33148251 DOI: 10.1186/s12920-020-00816-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
82 Peleli M, Moustakas A, Papapetropoulos A. Endothelial-Tumor Cell Interaction in Brain and CNS Malignancies. Int J Mol Sci 2020;21:E7371. [PMID: 33036204 DOI: 10.3390/ijms21197371] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
83 Henderson F, Jones E, Denbigh J, Christie L, Chapman R, Hoyes E, Claude E, Williams KJ, Roncaroli F, McMahon A. 3D DESI-MS lipid imaging in a xenograft model of glioblastoma: a proof of principle. Sci Rep 2020;10:16512. [PMID: 33020565 DOI: 10.1038/s41598-020-73518-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
84 Xiao K, Tan J, Yuan J, Peng G, Long W, Su J, Xiao Y, Xiao Q, Wu C, Qin C, Hu L, Liu K, Liu S, Zhou H, Ning Y, Ding X, Liu Q. Prognostic value and immune cell infiltration of hypoxic phenotype-related gene signatures in glioblastoma microenvironment. J Cell Mol Med 2020;24:13235-47. [PMID: 33009892 DOI: 10.1111/jcmm.15939] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
85 Renfrow JJ, Soike MH, West JL, Ramkissoon SH, Metheny-Barlow L, Mott RT, Kittel CA, D'Agostino RB Jr, Tatter SB, Laxton AW, Frenkel MB, Hawkins GA, Herpai D, Sanders S, Sarkaria JN, Lesser GJ, Debinski W, Strowd RE. Attenuating hypoxia driven malignant behavior in glioblastoma with a novel hypoxia-inducible factor 2 alpha inhibitor. Sci Rep 2020;10:15195. [PMID: 32938997 DOI: 10.1038/s41598-020-72290-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
86 Chen G, Liu B, Yin S, Li S, Guo Y, Wang M, Wang K, Wan X. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis 2020;9:81. [PMID: 32913192 DOI: 10.1038/s41389-020-00265-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 10.5] [Reference Citation Analysis]
87 Koike N, Kota R, Naito Y, Hayakawa N, Matsuura T, Hishiki T, Onishi N, Fukada J, Suematsu M, Shigematsu N, Saya H, Sampetrean O. 2-Nitroimidazoles induce mitochondrial stress and ferroptosis in glioma stem cells residing in a hypoxic niche. Commun Biol 2020;3:450. [PMID: 32807853 DOI: 10.1038/s42003-020-01165-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
88 Sun X, Lv X, Yan Y, Zhao Y, Ma R, He M, Wei M. Hypoxia-mediated cancer stem cell resistance and targeted therapy. Biomed Pharmacother 2020;130:110623. [PMID: 32791395 DOI: 10.1016/j.biopha.2020.110623] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 13.0] [Reference Citation Analysis]
89 Wang J, Xu S, Lv W, Shan A, Shi F, Xu J, Mei S, Yang Y. Identification and validation of hypoxic markers of glioblastoma multiforme in methylation, somatic CNV characteristics based on large-scale samples. J Biochem Mol Toxicol 2020;:e22585. [PMID: 32706934 DOI: 10.1002/jbt.22585] [Reference Citation Analysis]
90 Valable S, Gérault AN, Lambert G, Leblond MM, Anfray C, Toutain J, Bordji K, Petit E, Bernaudin M, Pérès EA. Impact of Hypoxia on Carbon Ion Therapy in Glioblastoma Cells: Modulation by LET and Hypoxia-Dependent Genes. Cancers (Basel) 2020;12:E2019. [PMID: 32718037 DOI: 10.3390/cancers12082019] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
91 Zhou C, Fan N, Liu F, Fang N, Plum PS, Thieme R, Gockel I, Gromnitza S, Hillmer AM, Chon SH, Schlösser HA, Bruns CJ, Zhao Y. Linking Cancer Stem Cell Plasticity to Therapeutic Resistance-Mechanism and Novel Therapeutic Strategies in Esophageal Cancer. Cells 2020;9:E1481. [PMID: 32560537 DOI: 10.3390/cells9061481] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
92 Cirotti C, Contadini C, Barilà D. SRC Kinase in Glioblastoma News from an Old Acquaintance. Cancers (Basel) 2020;12:E1558. [PMID: 32545574 DOI: 10.3390/cancers12061558] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
93 Salvati M, Tariciotti L, Brunetto GM, Gallo G, Santoro F, Frati A, Santoro A. Glioblastoma: Molecular profile and immunophenotypic analysis as prognostic tools for tailored therapy and decision making in a recent surgical series. Interdisciplinary Neurosurgery 2020;20:100697. [DOI: 10.1016/j.inat.2020.100697] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Bryukhovetskiy I, Shevchenko V, Arnotskaya N, Kushnir T, Pak O, Victor Z, Zaitsev S, Khotimchenko Y, Bryukhovetskiy A, Sharma A, Sharma HS. Transforming growth factor-β mimics the key proteome properties of CD133- differentiated and CD133+ cancer stem cells in glioblastoma. Int Rev Neurobiol 2020;151:219-42. [PMID: 32448609 DOI: 10.1016/bs.irn.2020.03.007] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
95 Lin W, Wu S, Chen X, Ye Y, Weng Y, Pan Y, Chen Z, Chen L, Qiu X, Qiu S. Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups. Front Oncol 2020;10:796. [PMID: 32500034 DOI: 10.3389/fonc.2020.00796] [Cited by in Crossref: 75] [Cited by in F6Publishing: 81] [Article Influence: 37.5] [Reference Citation Analysis]
96 Lange N, Urich J, Barz M, Aftahy K, Wagner A, Albers L, Bette S, Wiestler B, Bretschneider M, Meyer B, Gempt J. Metabolic Parameters Influence Brain Infarction and Outcome after Resection of Brain Metastases. Cancers (Basel) 2020;12:E1127. [PMID: 32365974 DOI: 10.3390/cancers12051127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Hübner M, Moellhoff N, Effinger D, Hinske CL, Hirschberger S, Wu T, Müller MB, Strauß G, Kreth FW, Kreth S. MicroRNA-93 acts as an "anti-inflammatory tumor suppressor" in glioblastoma. Neurooncol Adv 2020;2:vdaa047. [PMID: 32642700 DOI: 10.1093/noajnl/vdaa047] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
98 Engel AL, Lorenz NI, Klann K, Münch C, Depner C, Steinbach JP, Ronellenfitsch MW, Luger AL. Serine-dependent redox homeostasis regulates glioblastoma cell survival. Br J Cancer 2020;122:1391-8. [PMID: 32203214 DOI: 10.1038/s41416-020-0794-x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
99 Nusblat LM, Tanna S, Roth CM. Gene silencing of HIF-2α disrupts glioblastoma stem cell phenotype. Cancer Drug Resist 2020;3:199-208. [PMID: 32566921 DOI: 10.20517/cdr.2019.96] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
100 Wang S, Qi Y, Gao X, Qiu W, Liu Q, Guo X, Qian M, Chen Z, Zhang Z, Wang H, Xu J, Xue H, Guo X, Zhang P, Zhao R, Li G. Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma. Cell Death Dis 2020;11:168. [PMID: 32127518 DOI: 10.1038/s41419-020-2345-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 13.5] [Reference Citation Analysis]
101 Cristofaro I, Limongi C, Piscopo P, Crestini A, Guerriero C, Fiore M, Conti L, Confaloni A, Tata AM. M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition. Int J Mol Sci 2020;21:E1700. [PMID: 32131421 DOI: 10.3390/ijms21051700] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
102 Zhu Y, Liu X, Zhao P, Zhao H, Gao W, Wang L. Celastrol Suppresses Glioma Vasculogenic Mimicry Formation and Angiogenesis by Blocking the PI3K/Akt/mTOR Signaling Pathway. Front Pharmacol 2020;11:25. [PMID: 32116702 DOI: 10.3389/fphar.2020.00025] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 22.0] [Reference Citation Analysis]
103 Lan F, Yue X, Xia T. Exosomal microRNA-210 is a potentially non-invasive biomarker for the diagnosis and prognosis of glioma. Oncol Lett 2020;19:1967-74. [PMID: 32194691 DOI: 10.3892/ol.2020.11249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
104 Ezhilarasan D, Kumaran RI, Ramachandran I, Yadav S, Anbalagan M. Glioblastoma Stem Cells as a Therapeutic Target. Cancer Stem Cells: New Horizons in Cancer Therapies 2020. [DOI: 10.1007/978-981-15-5120-8_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Najafi M, Farhood B, Mortezaee K, Kharazinejad E, Majidpoor J, Ahadi R. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance. J Cancer Res Clin Oncol 2020;146:19-31. [PMID: 31734836 DOI: 10.1007/s00432-019-03080-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 19.7] [Reference Citation Analysis]
106 da Hora CC, Schweiger MW, Wurdinger T, Tannous BA. Patient-Derived Glioma Models: From Patients to Dish to Animals. Cells. 2019;8. [PMID: 31574953 DOI: 10.3390/cells8101177] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 19.0] [Reference Citation Analysis]
107 Qian M, Wang S, Guo X, Wang J, Zhang Z, Qiu W, Gao X, Chen Z, Xu J, Zhao R, Xue H, Li G. Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways. Oncogene 2020;39:428-42. [PMID: 31485019 DOI: 10.1038/s41388-019-0996-y] [Cited by in Crossref: 128] [Cited by in F6Publishing: 138] [Article Influence: 42.7] [Reference Citation Analysis]
108 Najafi M, Mortezaee K, Majidpoor J. Cancer stem cell (CSC) resistance drivers. Life Sci. 2019;234:116781. [PMID: 31430455 DOI: 10.1016/j.lfs.2019.116781] [Cited by in Crossref: 127] [Cited by in F6Publishing: 110] [Article Influence: 42.3] [Reference Citation Analysis]
109 Wolf KJ, Chen J, Coombes J, Aghi MK, Kumar S. Dissecting and rebuilding the glioblastoma microenvironment with engineered materials. Nat Rev Mater 2019;4:651-68. [PMID: 32647587 DOI: 10.1038/s41578-019-0135-y] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 20.0] [Reference Citation Analysis]
110 Hernández-SanMiguel E, Gargini R, Cejalvo T, Segura-Collar B, Núñez-Hervada P, Hortigüela R, Sepúlveda-Sánchez JM, Hernández-Laín A, Pérez-Núñez A, Sanz E, Sánchez-Gómez P. Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma. Oxid Med Cell Longev 2019;2019:9719730. [PMID: 31467641 DOI: 10.1155/2019/9719730] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
111 Hara A, Kanayama T, Noguchi K, Niwa A, Miyai M, Kawaguchi M, Ishida K, Hatano Y, Niwa M, Tomita H. Treatment Strategies Based on Histological Targets against Invasive and Resistant Glioblastoma. J Oncol 2019;2019:2964783. [PMID: 31320900 DOI: 10.1155/2019/2964783] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
112 Li C, Wang S, Yan JL, Torheim T, Boonzaier NR, Sinha R, Matys T, Markowetz F, Price SJ. Characterizing tumor invasiveness of glioblastoma using multiparametric magnetic resonance imaging. J Neurosurg 2019;132:1465-72. [PMID: 31026822 DOI: 10.3171/2018.12.JNS182926] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
113 Su H, Zou D, Sun Y, Dai Y. Hypoxia-associated circDENND2A promotes glioma aggressiveness by sponging miR-625-5p. Cell Mol Biol Lett 2019;24:24. [PMID: 30988674 DOI: 10.1186/s11658-019-0149-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
114 Hasan T, Caragher SP, Shireman JM, Park CH, Atashi F, Baisiwala S, Lee G, Guo D, Wang JY, Dey M, Wu M, Lesniak MS, Horbinski CM, James CD, Ahmed AU. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Cell Death Dis 2019;10:292. [PMID: 30926789 DOI: 10.1038/s41419-019-1387-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
115 Maurer GD, Heller S, Wanka C, Rieger J, Steinbach JP. Knockdown of the TP53-Induced Glycolysis and Apoptosis Regulator (TIGAR) Sensitizes Glioma Cells to Hypoxia, Irradiation and Temozolomide. Int J Mol Sci 2019;20:E1061. [PMID: 30823646 DOI: 10.3390/ijms20051061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
116 Serrano-Saenz S, Palacios C, Delgado-Bellido D, López-Jiménez L, Garcia-Diaz A, Soto-Serrano Y, Casal JI, Bartolomé RA, Fernández-Luna JL, López-Rivas A, Oliver FJ. PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism. Cell Death Dis 2019;10:51. [PMID: 30718520 DOI: 10.1038/s41419-018-1293-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
117 Hasan T, Caragher SP, Shireman JM, Park CH, Atashi F, Baisiwala S, Lee G, Guo D, Wu M, Wang JY, Dey M, Lesniak MS, Horbinski CM, James CD, Ahmed AU. Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma.. [DOI: 10.1101/454553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Yu W, Liang S, Zhang C. Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma. Neuromolecular Med 2018;20:452-74. [PMID: 30182330 DOI: 10.1007/s12017-018-8507-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
119 Renfrow JJ, Soike MH, Debinski W, Ramkissoon SH, Mott RT, Frenkel MB, Sarkaria JN, Lesser GJ, Strowd RE. Hypoxia-inducible factor 2α: a novel target in gliomas. Future Med Chem 2018;10:2227-36. [PMID: 30089425 DOI: 10.4155/fmc-2018-0163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
120 Chen W, Zebaze LN, Dong J, Chézeau L, Inquimbert P, Hugel S, Niu S, Bihel F, Boutant E, Réal E, Villa P, Junier MP, Chneiweiss H, Hibert M, Haiech J, Kilhoffer MC, Zeniou M. WNK1 kinase and its partners Akt, SGK1 and NBC-family Na+/HCO3- cotransporters are potential therapeutic targets for glioblastoma stem-like cells linked to Bisacodyl signaling. Oncotarget 2018;9:27197-219. [PMID: 29930759 DOI: 10.18632/oncotarget.25509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
121 Bryukhovetskiy I, Ponomarenko A, Lyakhova I, Zaitsev S, Zayats Y, Korneyko M, Eliseikina M, Mischenko P, Shevchenko V, Shanker Sharma H, Sharma A, Khotimchenko Y. Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review). Int J Mol Med 2018;42:691-702. [PMID: 29749540 DOI: 10.3892/ijmm.2018.3668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
122 Cornelison RC, Munson JM. Perspective on Translating Biomaterials Into Glioma Therapy: Lessons From in vitro Models. Front Mater 2018;5:27. [PMID: 30911536 DOI: 10.3389/fmats.2018.00027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
123 Bernstock J, Ye , Gessler , Peruzzotti-jametti , Gilbert , Pommier , Pluchino , Nakano , Hallenbeck . Topotecan Decreases the Expression of Programmed Death-Ligand 1 in Glioblastoma Cell Lines; Implications for Immunotherapy. Matters 2017. [DOI: 10.19185/matters.201709000008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
124 [DOI: 10.1101/2020.05.13.094268] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
125 Liu Q, Luo Q, Ju Y, Song G. Role of the mechanical microenvironment in cancer development and progression. Cancer Biol Med 2020;17:282-92. [PMID: 32587769 DOI: 10.20892/j.issn.2095-3941.2019.0437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Reference Citation Analysis]